Wisse L, Wuestefeld A, Murray M, Jagust W, La Joie R
Alzheimers Dement. 2025; 21(2):e14582.
PMID: 39985478
PMC: 11846482.
DOI: 10.1002/alz.14582.
Denning A, Ittyerah R, Levorse L, Sadeghpour N, Athalye C, Chung E
Acta Neuropathol. 2024; 148(1):37.
PMID: 39227502
PMC: 11371872.
DOI: 10.1007/s00401-024-02789-9.
Li R, Huang X, Shen L, Zhang T, Liu N, Hou X
Cell Mol Life Sci. 2024; 81(1):377.
PMID: 39212733
PMC: 11364739.
DOI: 10.1007/s00018-024-05383-0.
Ioannou K, Bucci M, Tzortzakakis A, Savitcheva I, Nordberg A, Chiotis K
Mol Psychiatry. 2024; 30(2):587-599.
PMID: 39179903
PMC: 11746147.
DOI: 10.1038/s41380-024-02672-9.
Calderon-Garciduenas L, Stommel E, Torres-Jardon R, Hernandez-Luna J, Aiello-Mora M, Gonzalez-Maciel A
Front Hum Neurosci. 2024; 17:1297467.
PMID: 38283093
PMC: 10811680.
DOI: 10.3389/fnhum.2023.1297467.
Distinguishing features of depression in dementia from primary psychiatric disease.
Fisher D, Dunn J, Dong H
Discov Ment Health. 2024; 4(1):3.
PMID: 38175420
PMC: 10767128.
DOI: 10.1007/s44192-023-00057-y.
Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms.
Walker L, Attems J
J Parkinsons Dis. 2023; 14(1):35-52.
PMID: 38143370
PMC: 10836576.
DOI: 10.3233/JPD-230154.
Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies.
Gaikwad S, Senapati S, Haque M, Kayed R
Alzheimers Dement. 2023; 20(1):709-727.
PMID: 37814508
PMC: 10841264.
DOI: 10.1002/alz.13490.
Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease.
Tosun D, Yardibi O, Benzinger T, Kukull W, Masters C, Perrin R
Alzheimers Dement. 2023; 20(1):421-436.
PMID: 37667412
PMC: 10843695.
DOI: 10.1002/alz.13447.
TDP-43-regulated cryptic RNAs accumulate in Alzheimer's disease brains.
Estades Ayuso V, Pickles S, Todd T, Yue M, Jansen-West K, Song Y
Mol Neurodegener. 2023; 18(1):57.
PMID: 37605276
PMC: 10441763.
DOI: 10.1186/s13024-023-00646-z.
Genome-Wide Meta-Analysis of Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Parkinson's Disease Cohorts.
Ta M, Blauwendraat C, Antar T, Leonard H, Singleton A, Nalls M
Mov Disord. 2023; 38(9):1697-1705.
PMID: 37539664
PMC: 11459375.
DOI: 10.1002/mds.29511.
Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias.
Hu W, Nayyar A, Kaluzova M
Neurotherapeutics. 2023; 20(4):955-974.
PMID: 37378862
PMC: 10457281.
DOI: 10.1007/s13311-023-01370-8.
Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated.
Robinson J, Xie S, Baer D, Suh E, Van Deerlin V, Loh N
Brain. 2023; 146(6):2557-2569.
PMID: 36864661
PMC: 10232273.
DOI: 10.1093/brain/awad059.
Neurodegenerative Diseases: Implications of Environmental and Climatic Influences on Neurotransmitters and Neuronal Hormones Activities.
Ayeni E, Aldossary A, Ayejoto D, Gbadegesin L, Alshehri A, Alfassam H
Int J Environ Res Public Health. 2022; 19(19).
PMID: 36231792
PMC: 9564880.
DOI: 10.3390/ijerph191912495.
Poststroke Cognitive Impairment: A Longitudinal Follow-Up and Pre/Poststroke Mini-Mental State Examination Comparison.
Hong C, Lee H, Chung C, Chiu W, Lee T, Chen D
Curr Alzheimer Res. 2022; 19(10):716-723.
PMID: 35927922
DOI: 10.2174/1567205019666220802151945.
Neuropathology of depression in non-demented older adults: A large postmortem study of 741 individuals.
Nunes P, Suemoto C, Rodriguez R, Leite R, Nascimento C, Pasqualucci C
Neurobiol Aging. 2022; 117:107-116.
PMID: 35709536
PMC: 9970030.
DOI: 10.1016/j.neurobiolaging.2022.05.007.
Biological aging processes underlying cognitive decline and neurodegenerative disease.
Gonzales M, Garbarino V, Pollet E, Palavicini J, Kellogg Jr D, Kraig E
J Clin Invest. 2022; 132(10).
PMID: 35575089
PMC: 9106343.
DOI: 10.1172/JCI158453.
Characterizing Amyloid-Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.
Josephs K, Weigand S, Whitwell J
Neurology. 2022; 98(22):e2282-e2292.
PMID: 35314506
PMC: 9162162.
DOI: 10.1212/WNL.0000000000200287.
Regional cerebral hypometabolism on 18F-FDG PET/CT scan in delirium is independent of acute illness and dementia.
Nitchingham A, Pereira J, Wegner E, Oxenham V, Close J, Caplan G
Alzheimers Dement. 2022; 19(1):97-106.
PMID: 35289980
PMC: 10078760.
DOI: 10.1002/alz.12604.
Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives.
Fisher R, Miners J, Love S
Brain Pathol. 2022; 32(6):e13061.
PMID: 35289012
PMC: 9616094.
DOI: 10.1111/bpa.13061.